Search research articles
Contact Us
Filters
Showing results (51-60 of 54) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 54 results.
Advanced Materials (Deerfield Beach, Fla.)
|
December 15, 2023
Thorough Optimization for Intrinsically Stretchable Organic Photovoltaics
Xiangjun Zheng, Xiaoling Wu, Qiang Wu, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
July 8, 2026
Synergistically Enhancing Light Harvesting and Mechanical Flexibility for Ultra-Flexible Organic Biosensors
Xiangjun Zheng, Yibo Kong, Sixing Xiong, et al.
Cancer Chemotherapy and Pharmacology
|
May 14, 2017
Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 study
Yun Leng, Jian Hou, Jie Jin, et al.
BMC Cancer
|
October 14, 2023
Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial
Zhongjun Xia, Yun Leng, Baijun Fang, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 54) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 54 results.
Advanced Materials (Deerfield Beach, Fla.)
|
December 15, 2023
Thorough Optimization for Intrinsically Stretchable Organic Photovoltaics
Xiangjun Zheng, Xiaoling Wu, Qiang Wu, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
July 8, 2026
Synergistically Enhancing Light Harvesting and Mechanical Flexibility for Ultra-Flexible Organic Biosensors
Xiangjun Zheng, Yibo Kong, Sixing Xiong, et al.
Cancer Chemotherapy and Pharmacology
|
May 14, 2017
Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 study
Yun Leng, Jian Hou, Jie Jin, et al.
BMC Cancer
|
October 14, 2023
Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial
Zhongjun Xia, Yun Leng, Baijun Fang, et al.
Page
of 6